CHI3L1 and early-onset autosomal dominant Alzheimer disease: Additionally, CSF YKL-40 levels may be associated with the progression of the disease as it increased longitudinally in mild cognitive impairment and Alzheimer’s disease patients but not in persons with normal cognitive function [153] (Table 2).